Centessa Pharmaceuticals PLC
F:260
Centessa Pharmaceuticals PLC
F:260
Price:
34.6
EUR
Market Cap:
€3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Centessa Pharmaceuticals PLC
F:260
|
UK |
|
R
|
RTL Group SA
XMUN:RRTL
|
LU |
|
A
|
Align Technology Inc
SWB:AFW
|
US |
|
A
|
Archrock Inc
XBER:54E
|
US |
|
Advanced Info Service PCL
OTC:AVIFY
|
TH |
|
I
|
Ingevec SA
SGO:INGEVEC
|
CL |
|
S
|
Singapore Telecommunications Ltd
OTC:SGAPY
|
SG |
|
Flughafen Zuerich AG
OTC:FLGZY
|
CH |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
H
|
Heidelberg Pharma AG
XBER:HPHA
|
DE |
|
D
|
Discovery Ltd
XMUN:D3H
|
ZA |
|
Eltel AB
LSE:0R53
|
SE |
|
B
|
Booking Holdings Inc
F:PCE1
|
US |
|
E
|
Eltel AB
F:E5E
|
SE |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
T
|
Thai Beverage PCL
F:T6W
|
TH |
|
K
|
Kosmos Energy Ltd
F:KOS1
|
US |
|
Japan Tobacco Inc
OTC:JAPAF
|
JP |
Multiples-Based Value
The Multiples-Based Value for 
Centessa Pharmaceuticals PLC (260) under the Base Case is hidden
EUR.
Compared with the current market price of 34.6 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Centessa Pharmaceuticals PLC Multiples-Based Value
LOCKED
